ArticleLancet (London, England)2021
Tocilizumab in COVID-19 therapy: who benefits, and how?
Chengliang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleLancet (London, England)2021
Chengliang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.